USPTO Patent Review Authority
A recent Law360 article, featuring Partner Kelly Kubasta, examines growing bipartisan concern over the expanding role of the U.S. Patent and Trademark Office Director in overseeing patent reviews. Both the current Director, John Squires , and the former Director, Kathi Vidal , have faced similar scrutiny from Congress for their use of discretionary authority following the U.S. v. Arthrex decision, which granted the Director greater control over Patent Trial and Appeal Board proceedings. Lawmakers across both parties have raised concerns about whether this authority is being exercised within the bounds intended by Congress, particularly as policies and outcomes appear to shift between administrations.
The article highlights how differing leadership approaches have led to significant changes in how patent challenges are handled, raising broader questions about transparency, consistency, and the potential for political influence in the patent system. Kelly notes that these concerns reflect an ongoing tension between agency rulemaking and legislative authority. As debate continues, the issue underscores the importance of maintaining a balanced and predictable framework for patent review, one that supports innovation while ensuring fairness and clarity for businesses and stakeholders.
To read the full article in Law360, click here (subscription required).